Logo image of ASG.CA

AURORA SPINE CORP (ASG.CA) Stock Fundamental Analysis

TSX-V:ASG - TSX Venture Exchange - CA05206X1087 - Common Stock - Currency: CAD

0.3225  +0.01 (+4.03%)

Fundamental Rating

3

ASG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Equipment & Supplies industry. ASG may be in some trouble as it scores bad on both profitability and health. ASG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ASG has reported negative net income.
ASG had a negative operating cash flow in the past year.
ASG had negative earnings in each of the past 5 years.
In multiple years ASG reported negative operating cash flow during the last 5 years.
ASG.CA Yearly Net Income VS EBIT VS OCF VS FCFASG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M

1.2 Ratios

ASG has a Return On Assets of -5.26%. This is amongst the best in the industry. ASG outperforms 92.86% of its industry peers.
With an excellent Return On Equity value of -12.65%, ASG belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
ROA -5.26%
ROE -12.65%
ROIC N/A
ROA(3y)-17.06%
ROA(5y)-14.65%
ROE(3y)-36.29%
ROE(5y)-37.38%
ROIC(3y)N/A
ROIC(5y)N/A
ASG.CA Yearly ROA, ROE, ROICASG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

1.3 Margins

With a decent Gross Margin value of 60.39%, ASG is doing good in the industry, outperforming 78.57% of the companies in the same industry.
In the last couple of years the Gross Margin of ASG has remained more or less at the same level.
ASG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y1.34%
ASG.CA Yearly Profit, Operating, Gross MarginsASG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

ASG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ASG has more shares outstanding
ASG has more shares outstanding than it did 5 years ago.
ASG has a worse debt/assets ratio than last year.
ASG.CA Yearly Shares OutstandingASG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ASG.CA Yearly Total Debt VS Total AssetsASG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of 0.63, we must say that ASG is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.63, ASG is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
ASG has a Debt/Equity ratio of 0.68. This is a neutral value indicating ASG is somewhat dependend on debt financing.
ASG has a Debt to Equity ratio (0.68) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC7.04%
ASG.CA Yearly LT Debt VS Equity VS FCFASG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 2.40 indicates that ASG has no problem at all paying its short term obligations.
ASG has a better Current ratio (2.40) than 78.57% of its industry peers.
A Quick Ratio of 1.38 indicates that ASG should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.38, ASG is doing good in the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 1.38
ASG.CA Yearly Current Assets VS Current LiabilitesASG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

ASG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.39%, which is quite impressive.
Looking at the last year, ASG shows a very strong growth in Revenue. The Revenue has grown by 20.01%.
Measured over the past years, ASG shows a quite strong growth in Revenue. The Revenue has been growing by 10.83% on average per year.
EPS 1Y (TTM)74.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y18.87%
Revenue growth 5Y10.83%
Sales Q2Q%20.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASG.CA Yearly Revenue VS EstimatesASG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
ASG.CA Yearly EPS VS EstimatesASG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ASG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASG.CA Price Earnings VS Forward Price EarningsASG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ASG's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ASG is cheaper than 92.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.78
ASG.CA Per share dataASG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA SPINE CORP

TSX-V:ASG (3/7/2025, 7:00:00 PM)

0.3225

+0.01 (+4.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-21 2024-11-21
Earnings (Next)04-28 2025-04-28
Inst Owners0%
Inst Owner ChangeN/A
Ins Owners26.02%
Ins Owner ChangeN/A
Market Cap24.90M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.03
P/FCF N/A
P/OCF N/A
P/B 3.46
P/tB 4.12
EV/EBITDA 34.78
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.31
BVpS0.09
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.26%
ROE -12.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.39%
FCFM N/A
ROA(3y)-17.06%
ROA(5y)-14.65%
ROE(3y)-36.29%
ROE(5y)-37.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y1.34%
F-Score6
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 5.89
Cap/Depr 37.43%
Cap/Sales 2.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 1.38
Altman-Z 0.63
F-Score6
WACC7.04%
ROIC/WACCN/A
Cap/Depr(3y)85.76%
Cap/Depr(5y)85.1%
Cap/Sales(3y)5.33%
Cap/Sales(5y)5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20.01%
Revenue growth 3Y18.87%
Revenue growth 5Y10.83%
Sales Q2Q%20.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y77.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y90.36%
OCF growth 3YN/A
OCF growth 5YN/A